February 23, 2018
Rose
Teva Pharmaceuticals announced it would sell a “lower-cost” alternative to Syprine, an old drug that costs more than $21,000. But the new generic version costs nearly as much.
from Health http://ift.tt/2olKSjk
February 23, 2018
Rose
Health, Health - The New York Times
No comments
Related Posts:
Without a big aid bill like Biden’s, jobs will be slow to rebound, Yellen warns.- Virus Variant First Found in Britain Now Spreading Rapidly in U.S.
- Will the Super Bowl Cause a Coronavirus Surge?
- The Super Bowl brings fears of another coronavirus surge.
- Emil Freireich, Groundbreaking Cancer Researcher, Dies at 93
Subscribe to:
Post Comments (Atom)
0 comments:
Post a Comment